Family planning has been shown to be an effective
intervention for promoting maternal, newborn and child health. Despite family
planning's multiple benefits, women's experiences of - or concerns related
to - side effects present a formidable barrier to the sustained use of contraceptives,
particularly in the postpartum period. This paper presents perspectives of
postpartum, rural, Tanzanian women, their partners, public opinion leaders and
community and health facility providers related to side effects associated with
contraceptive use.
Qualitative interviews were conducted with postpartum women (n = 34), their partners (n = 23), community leaders (n = 12) and health providers based
in both facilities (n = 12)
and communities (n = 19)
across Morogoro Region, Tanzania. Following data collection, digitally recorded
data were transcribed, translated and coded using thematic analysis.
Respondents described family planning positively due to the
health and economic benefits associated with limiting and spacing births.
However, side effects were consistently cited as a reason that women and their
partners choose to forgo family planning altogether, discontinue methods,
switch methods or use methods in an intermittent (and ineffective) manner.
Respondents detailed side effects including excessive menstrual bleeding,
missed menses, weight gain and fatigue. Women, their partners and community
leaders also described concerns that contraceptives could induce sterility in
women, or harm breastfeeding children via contamination of breast milk. Use of
family planning during the postpartum period was viewed as particularly
detrimental to a newborn’s health in the first months of life.
To meet Tanzania’s national target of increasing
contraceptive use from 34 to 60 % by 2015, appropriate counseling and
dialogue on contraceptive side effects that speaks to pressing concerns
outlined by women, their partners, communities and service providers are
needed.
Full article at: http://goo.gl/Oj1Ke1
By: Joy J. Chebet1*, Shannon A. McMahon12, Jesse A. Greenspan1, Idda H. Mosha3, Jennifer A. Callaghan-Koru1, Japhet Killewo4, Abdullah H. Baqui1 and Peter J. Winch1
1Department of International Health, Johns
Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, Baltimore, MD,
USA
2Institute of Public Health,
Ruprecht-Karls-Universität, Im Neuenheimer Feld 324, Heidelberg, 69120,
Germany
3Department of Behavioural Sciences,
Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania
4Department of Epidemiology and Biostatistics,
Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania
More at: https://twitter.com/hiv_insight
No comments:
Post a Comment